Mexico kicks off Covid vaccination campaign with Pfizer-BioNTech candidate

Mexico has kicked off its vaccination campaign against the novel coronavirus, with a vaccine developed by US laboratory Pfizer and its German partner BioNTech.

Pfizer vaccine
Pfizer Covid-19 vaccine
IANS Mexico City
2 min read Last Updated : Dec 25 2020 | 9:39 AM IST

Mexico has kicked off its vaccination campaign against the novel coronavirus, with a vaccine developed by US laboratory Pfizer and its German partner BioNTech.

With healthcare workers prioritized, the first person to be vaccinated on Thursday was Maria Irene Ramirez, head of nursing at the intensive care unit of the Ruben Lenero Hospital in Mexico City, the capital and one of the regions hit the worst by the pandemic, with 302,199 confirmed cases and 20,472 deaths, reports Xinhua news agency.

At the launch ceremony, Deputy Health Minister Hugo Lopez-Gatell noted that while the pandemic is not over, "with the vaccine it will be possible to combat it more effectively".

"Today, December 24, vaccination against Covid-19 begins and today the management of the pandemic changes with a light of hope," said Lopez-Gatell during the event, which was broadcast live as part of Mexican President Andres Manuel Lopez Obrador's daily morning press conference.

Vaccination began a day after the first 3,000 doses arrived from Pfizer-BioNTech laboratories, the first of 1.4 million doses expected to be delivered by January 31, 2021.

Mexico currently accounts for the world's fourth highest coronavirus death toll and the 13th largest caseload.

As of Friday, the country's overall confirmed cases and deaths stood at 1,350,079 and 121,172, respectively.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMexicoCoronavirus VaccinePfizerHealth crisis

First Published: Dec 25 2020 | 9:21 AM IST

Next Story